Trial Profile
Heart Failure Prevention for Women: Preservation of Cardiac Function in the Peri-Menopausal Woman Through Hormone Therapy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol/norethisterone (Primary)
- Indications Menopausal syndrome
- Focus Pharmacodynamics
- 29 Mar 2017 Status changed from recruiting to discontinued as enrollment goals not being met
- 02 Nov 2016 Planned End Date changed from 1 Oct 2016 to 1 Oct 2018.
- 02 Nov 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2018.